fbpx

PTCB Guide to SERMs.

Icon Published Date: Apr 9th, 2026
Icon Last Updated: Apr 15th, 2026
ptcb guide to SERMs

PTCB Exam Focus – SERMs.

SERMs are a group of drugs that act on estrogen receptors. Hence the acronym; selective estrogen receptor modulators. These drugs are used to treat conditions such as infertility, osteoporosis, and breast cancer.

For the PTCB exam, pharmacy technicians are required to know all major SERMs used in clinical practice, typically those listed in the Top 200 medicines. Though SERMs may not be the largest nor the most important drug class to study for the exam, learning this class does offer easy marks. By the end of this guide, we will cover all key details that technicians need to know.

In summary, pharmacy technicians should study:

  • The definition of a “SERM” drug
  • Indications – what each SERM is used to treat
  • Major examples of SERMs used in medicine
  • Any clinically significant side effects or drug interactions
  • Major brand names

SERMs constitute an important but small class of drugs used in medicine. This makes learning about this drug class more digestible and manageable compared to many other drug classes.

What are technicians not required to learn?

Pharmacy technicians are not required to learn mechanisms in significant detail.

For this drug class, it is sufficient for technicians to understand that SERMs act on estrogen receptors in the body. What’s unique about SERMs is that they can act like estrogen in some tissues but block estrogen in other tissues – a dual effect.

That’s because estrogen receptors of different types exist in different parts of the body (breast, bone, uterus, etc.). SERMs “selectively” act differently depending on the tissue.

For example:

  • SERMs can block estrogen receptors in breast tissue, making them effective for the treatment of breast cancer.
  • They can simultaneously mimic the effects of estrogen in bone, helping to maintain bone density in osteoporosis.

For the purposes of the PTCB exam, pharmacy technicians should only understand this dual nature of how SERMs work.

However, detailed assessments of individual SERM mechanisms are not required and will not be tested.

What are SERMs used to treat?

The primary indications of SERMs are:

  • Breast cancer
  • Osteoporosis
  • Infertility

Below you can find more details on SERMs that technicians should know, their indications, as well as notable clinical details on each.

Note that SERMs can be easily identified by their suffixes:

  • -ifene / -iphene
  • -ifen
SERMIndicationsClinical factors
TamoxifenBreast cancer (treatment & prevention)Blocks estrogen in breast tissue; increased risk of endometrial cancer
RaloxifeneOsteoporosis prevention/treatment; breast cancer risk reductionProtects bone; lower endometrial risk than tamoxifen
ClomipheneInfertility (induces ovulation)Stimulates ovulation by increasing hormone release
ToremifeneMetastatic breast cancerSimilar to tamoxifen but less commonly used
BazedoxifeneOsteoporosis (often with estrogen)Used in postmenopausal women
OspemifeneDyspareunia (painful intercourse) due to menopauseActs like estrogen in vaginal tissue

Side Effects and Interactions.

Pharmacy technicians are only required to learn major side effects and interactions with SERMs.

These include:

  • hot flashes, nausea, mood swings, fatigue, and leg cramps
  • serious risks include venous thromboembolism (blood clots), such as deep vein thrombosis and pulmonary embolism
  • tamoxifen can increase the risk of endometrial cancer due to estrogen effects on the uterus
  • SERMs can interact with anticoagulants like warfarin, increasing bleeding risk
  • clomiphene increases the risk of multiple pregnancies, including twins and triplets

Note that patients taking SERMs should avoid prolonged immobility and report symptoms like leg pain, chest pain, or abnormal vaginal bleeding promptly.

Brand Names.

SERMBrand name
TamoxifenNolvadex (discontinued)
Generic formulations widely available.
RaloxifeneEvista
ClomipheneClomid
ToremifeneFareston (discontinued)
Generic formulations widely available.
BazedoxifeneDuavee (with conjugated estrogens)
OspemifeneOsphena

PTCB Sample Exam Questions.

Below you can find five sample PTCB exam questions on the topic of SERMs.

These five questions reflect the type of questions that get tested about SERMs on the exam – both the style and difficulty. As always, have a go at the questions yourself before comparing your answers with the explanations (in the section below).

Question 1.

Identify the SERM from the following list of drugs:

a. methotrexate

b. degarelix

c. methylprednisolone

d. raloxifene

Question 2.

Hot flashes, mood swings, and leg cramps are common side effects of which drug class?

a. MAO inhibitors

b. NSAIDs

c. SERMs

d. DMARDs

Question 3.

Which of these drugs is used in the treatment of infertility?

a. clomiphene

b. bazedoxifene

c. toremifene

d. raloxifene

Question 4.

Tamoxifen is a drug primarily used in the treatment of which condition?

a. osteoporosis

b. breast cancer

c. benign prostatic hyperplasia

d. hypothyroidism

Question 5.

What is the active ingredient of the medicine, Duavee?

a. bazedoxifene

b. clomiphene

c. ospemifene

d. toremifene

Answer Explanations.

Answer to Question 1 – d. Raloxifene

It’s common on the PTCB exam for pharmacy technicians to be asked to identify a drug type from a list of drugs. In this case, raloxifene is the only SERM listed; a drug used to treat or prevent osteoporosis.

Methotrexate is a DMARD / anticancer drug; degarelix is a GnRH antagonist used to treat prostate cancer; and methylprednisolone is a corticosteroid.

Answer to Question 2 – c. SERMs

Common side effects of SERMs include hot flashes, mood swings, leg cramps, and vaginal dryness or discharge.

More seriously, SERMs can increase the risk of blood clots.

Answer to Question 3 – a. Clomiphene

Clomiphene is a SERM that is used to promote ovulation in women with infertility. This is the reason why the drug increases the risk of twins and triplets.

Answer to Question 4 – b. Breast cancer

Tamoxifen is a drug primarily used to treat breast cancer. Less commonly, the drug is used to treat menstrual pain and infertility.

Answer to Question 5 – a. Bazedoxifene

Bazedoxifene is the active ingredient of the medicine Duavee. It is used to treat osteoporosis in combination with conjugated estrogens.

PTCB Cheat Sheet on SERMs.

  • SERMs = Selective Estrogen Receptor Modulators
  • Key examples: tamoxifen, toremifene, raloxifene, bazedoxifene, ospemifene, clomiphene
  • Key drug suffixes: -ifen / -iphene / -ifene
  • SERMs are a class of drugs that act as estrogen agonists or antagonists depending on tissue type (breast, bone, uterus etc.)
  • In breast tissue: block estrogen → used for breast cancer (e.g. tamoxifen)
  • In bone: mimic estrogen → help prevent osteoporosis (e.g. raloxifene)
  • Used for infertility: clomiphene induces ovulation; increases risk of multiple pregnancies
  • Used for dyspareunia: ospemifene acts on vaginal tissue
  • Common side effects: hot flashes, nausea, mood swings, leg cramps, fatigue
  • Serious effects: venous thromboembolism (DVT/PE); blood clots
  • Tamoxifen-specific: increased risk of endometrial cancer
  • Drug interactions: increased risk of bleeding when taken with warfarin
  • Key brand names: Clomid (clomiphene); Evista (raloxifene); Duavee (bazedoxifene); Osphena (ospemifene). Generic formulations are available for both tamoxifen and toremifene.

Hope you found this week’s PTCB guide to SERMs helpful!

Master this & every other topic of the PTCB exam by becoming a full member of our test prep program – all the features and course materials you need to pass the PTCB exam on your first attempt.

Share Article to:

PTCB Test Prep Logo

Written by:

PTCB Test Prep Editorial Team

PTCB Test Prep has developed e-learning resources for pharmacy technicians since 2019. Our editorial team researches and updates each study guide using authoritative sources. Content is regularly reviewed and updated for accuracy, clarity and alignment with the current PTCE content outline.

Check our editorial policy.